 |
| june
3, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
WEEKLY CEO Q&A:
Robin Toft, CEO, Curebound |
|
In this Q&A, Robin talks about her
career pivot into the nonprofit sector,
the collaborative research model that sets
Curebound apart, the growing role of
philanthropic capital to fill funding
gaps, and what it takes to build both a
high-performing team and a research
accelerator with staying power. More |
|
|
 |
Our
Newest Location: Mispro San
Diego!
Reserve
your space today in our Sorrento
Mesa
Contract Vivarium |
|
Learn More
→ |
|
|
- Cardiff
Oncology: Presentation of Positive Results
From Its Randomized, Controlled Phase 2
Trial of Onvansertib in First-Line
RAS-Mutated mCRC at the 2026 ASCO Annual
Meeting More
More
- Crinetics
and Leading Patient Groups: Launch 'Everyday
Advocacy' Initiative to Empower People Across
Endocrine Disease Communities More
- Dexcom:
Releases Customer Advisory Council Report,
Outlining Ongoing Commitments to Enhancing
Product Performance and User Experience More
- Heron:
U.S. District Court Issues Decision Regarding
CINVANTI Patents More
- Kura
Oncology: Highlights Darlifarnib's Potential
as a Foundational Combination Platform for
KRAS-Mutant Cancers and Outlines Development
Strategy More
- n-Lorem:
New Publication Provides an Unprecedented Look
at the Largest Reported Cohort of Nano-Rare
Patients Evaluated for Individualized ASO
Therapies More
- Oncotelic
Therapeutics: Sapu Nano Expands International
Development of Sapu003 and Appoints Global
Clinical Trials (GCT) as Lead CRO for Phase 1b
Program More
- QuidelOrtho
and Allo Hope Foundation: Join Forces to
Advance Education, Connection and Early
Testing for Alloimmunized Pregnancies More
|
|
 |
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Equillium: Inducement Grants Under Nasdaq
Listing Rule 5635(c)(4) More
- Fate Therapeutics: New Employee Inducement
Awards Under Nasdaq Listing Rule 5635(c)(4) More
- Gossamer Bio: Early Tender Results and Early
Settlement for Exchange Offer and Consent
Solicitation With Respect to Existing
Convertible Notes More
- Maravai LifeSciences: Refinancing of Credit
Agreement, Extending Maturity to 2032 More
- More on Travere Scaling Everest With
$1.1B Deal for BTK Inhibitor Aimed at Rare
Kidney Diseases More
More*
|
|
 |
| Biotech’s
most flexible vivarium lab space
to launch and scale studies. |
|
Learn More
→ |
|
|
- AI in Medical Affairs: How Pharma Is
Becoming a Real-Time Scientific Intelligence
System More
- Big4Bio CEO Weekly Q&A: Robin Toft,
CEO, Curebound More
- Cross-Reactive T Cells Could Point to
Broad Vaccines or Treatments for Measles,
Nipah Virus More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- Telling Your Science Story to
Investors More
- AI in Biotech: The New
Frontier for Leadership & Strategy More
- David Chang to Hand Over the Reins at
Allogene; Ex-Esperion CEO Gets Started at
Phlow More*
- Empowering Students Through STEM: A
Conversation With Massachusetts Science &
Engineering Fair Executive Director Helen
Rosenfeld More
- Hiring Outlook: Job Opportunities on
BioSpace Rise YOY, but Layoffs Affect
Thousands More
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- More Than Executive Search: Building
Leadership for Every Stage of Growth More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: San Diego Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:San
Diego, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
